Related Experiment Video
Updated: Jan 18, 2026

09:18
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
3.0K
Polymyxin B-related neurotoxicity: a brief case report
Izgi Bayraktar1, Burcin Halacli2, Kutay Demirkan3
1Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Turkey izgibayraktar@gmail.com.
Summary
Polymyxin B can cause neurotoxicity, leading to numbness and tingling. Promptly discontinuing the antibiotic and switching to colistimethate can improve symptoms in patients with drug-resistant infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Neurology
Background:
- Polymyxins (polymyxin B and colistin) are last-resort antibiotics for multidrug-resistant bacterial infections.
- These antibiotics carry risks of adverse effects, including nephrotoxicity and neurotoxicity.
- Acinetobacter baumannii is a significant pathogen in healthcare-associated infections.
Keywords:
CLINICAL MEDICINECase ReportsCritical CareDRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONSMICROBIOLOGYMore Related Videos
Related Concept Videos
Local Anesthetics: Adverse Effects
758
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
758
Depolarizing Blockers: Pharmocokinetics
567
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567

